About Inven Pharmaceuticals Private Limited
Data last updated:
Inven Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 December 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1984PTC002701. Its GSTIN is 23AAACI3953M1ZH (Madhya Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹45 Lakh and a paid-up capital of ₹32 Lakh. It is led by directors including Urvashi Patni (Managing Director) and Manju Patni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 27/1 Patel Nagar Main Road, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.99 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹9.53 Lakh (net margin 0.3%) and EBITDA of ₹89.77 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The company has about 85 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.02 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 12 cases involving the company, including 6 filed by the company and 6 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website inven.co.in.
Company details
Contact details
Inven Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its website is inven.co.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address27/1 Patel Nagar Main Road, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Inven Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inven Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Inven Pharmaceuticals Private Limited, buy the company report.
Financials of Inven Pharmaceuticals Private Limited
FY 2025 filings availableInven Pharmaceuticals Private Limited reported revenue of ₹27.99 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹89.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inven Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inven Pharmaceuticals Private Limited
Inven Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Urvashi Patni | Managing Director | 05 Nov 2024 | 1 Years 11 Months | Current |
| Manju Patni | Whole-Time Director | 17 Jun 2006 | 20 Years 4 Months | Current |
| Sohil Patni | Whole-Time Director | 05 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Inven Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indus Pharma Private Limited | ₹28.11 Cr (FY 2023) | -58.0% | New Delhi, Delhi, India | |||
| Inven Pharmaceuticals Private Limitedthis company | ₹27.99 Cr (FY 2025) | ₹9.53 Lakh | 0.3% | -6.0% | 85 | Indore, Madhya Pradesh, India |
| Aashka Formulation Private Limited | ₹27.95 Cr (FY 2022) | 904.0% | Kalol, Gujarat, India | |||
| Danashmand Organic Private Limited | ₹27.92 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Shreepati Pharmaceuticals Pvt Ltd | ₹27.91 Cr (FY 2025) | 7.0% | Indore, M.P, Madhya Pradesh, India | |||
| Sellwell Pharmaceuticals Limited | ₹27.85 Cr (FY 2024) | -21.0% | Madhya Pradesh, India | |||
| Memphis Vision Care Private Limited | ₹27.83 Cr (FY 2024) | 106.0% | Chhatral, Gujarat, India |
To see the full peer comparison of Inven Pharmaceuticals Private Limited, buy the company report.
Auditor
Inven Pharmaceuticals Private Limited is audited by P.D.NAGAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.D.NAGAR & CO. | FY 2023 | 001231C |
Shareholding
The shareholding of Inven Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Inven Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2009 | 10193794 | Hdfc Bank Limited | ₹9 Cr | Open | |
| 29 Oct 1990 | 90207119 | State Bank of Indore | ₹1.92 Lakh | Open | |
| 17 Jan 1995 | 90205000 | State Bank of Indore | ₹10 Lakh | Satisfied | |
| 17 Jan 1995 | 90207571 | State Bank of Indore | ₹15 Lakh | Satisfied | |
| 29 Mar 1994 | 90204943 | Madhya Pradesh Finance Corporation | ₹11 Lakh | Satisfied |
To see the full charge records of Inven Pharmaceuticals Private Limited, buy the company report.
Total charge records: 17 View all charges
Legal cases
Inven Pharmaceuticals Private Limited has 12 court cases on record: 6 filed by Inven Pharmaceuticals, 6 filed against it. 3 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 4 | 3 | 2 |
| Supreme Court | 3 | 3 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (A482) | Filed by the company against State of U.P. Thru. Prin. Secy. Lko. and Another | Pending |
| District court, Shravasti, Uttar Pradesh | Criminal case | Filed against the company by State | Pending |
| District court, Hamirpur, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Filed against the company by State of HP | Pending |
| District court, Hamirpur, Himachal Pradesh | Court case (Cr. M. A.) | Filed against the company by State of HP Hrough Drugs Inspector Hamirpur HP | Disposed |
| High Court, Rajasthan | Criminal miscellaneous application | Filed by the company against State of Rajasthan Through Shri Prahlad Meena, Drug Control Officer, Rajasthan Headquarter | Disposed |
To see the full case history of Inven Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inven Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Inven Pharmaceuticals Private Limited has a workforce of 85 employees on its EPFO records as of Sep 24, 2025, across 1 active EPFO establishment.
GST
Inven Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACI3953M1ZH | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Inven Pharmaceuticals Private Limited, buy the company report.
Recent activity
Inven Pharmaceuticals Private Limited has 6 board changes on record since 2006: 3 appointments and 3 cessations. The latest: Urvashi Patni was appointed as Managing Director on 05 Nov 2024.
43 earlier events are in the company report.
Frequently asked questions
Inven Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 December 1984 (42+ years old) and is registered under CIN U24232MP1984PTC002701.
Inven Pharmaceuticals has 3 current directors:
- Urvashi Patni - Managing Director
- Manju Patni - Whole-Time Director
- Sohil Patni - Whole-Time Director
The latest financial statements of Inven Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inven Pharmaceuticals is 23AAACI3953M1ZH, registered in Madhya Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Inven Pharmaceuticals is U24232MP1984PTC002701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inven Pharmaceuticals has 12 court cases on record: 6 filed by the company and 6 filed against it. 3 are pending. Most are in the high courts.
Inven Pharmaceuticals was incorporated on 24 December 1984, making it 42+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Inven Pharmaceuticals by revenue are Indus Pharma Private Limited, Aashka Formulation Private Limited, Danashmand Organic Private Limited, Shreepati Pharmaceuticals Pvt Ltd, Sellwell Pharmaceuticals Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Urvashi Patni was appointed as Managing Director on 05 Nov 2024. Lalchand Patni ceased to be Whole-Time Director on 24 Jul 2018. Urvashi Patni ceased to be Whole-Time Director on 29 Sep 2016. Inven Pharmaceuticals has 6 board changes on record in total.
Inven Pharmaceuticals can be reached through the website inven.co.in. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Inven Pharmaceuticals is at 271 Patel Nagar Main Road, Indore, Madhya Pradesh, India – 452001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
